CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 300 enrolled
Drug / intervention
Lactoferrin +2 moredrug
Likely dose
Iron Supplement 150 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03542825
NCT03542825Phase 4Completed
CompareCT.gov

Outcome of Oral Lactoferrin in Comparison to Amino Acid Chelated Iron and Ferrous Sulphate Supplementation During Pregnancy: A Randomized Control Trial

South Valley University·interventional·Posted May 31, 2018·Updated Dec 28, 2018

In Brief

A Phase 4 clinical trial evaluating Lactoferrin, Iron Supplement, and 1 other intervention for Iron-deficiency. Completed, enrolled 300 participants across 1 site.

Detailed Summary

Iron deficiency anemia (IDA) is the condition in which there is anemia due to a lack of iron. The oral route is preferred to the parenteral route to replace iron stores \[Sharma JB; et al., 2004\]. Inorganic iron has poor bio-availability in addition to many side effects, including gastrointestinal discomfort, nausea, vomiting, diarrhea and constipation and it may sometimes increase susceptibility to infection \[ So¨lvell L; et al., 1970\].

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIron-deficiency
CountriesEgypt
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedMay 31, 2018
Enrollment StartJan 1, 2018
Primary CompletionSep 1, 2018
Study CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 8.1 years ago

Interventions

Lactoferrindrug

parallel use of the three drugs to compare the efficacy of each arm in prevention of anemia

Iron Supplementdrug

Iron Sulphate 150 mg once daily

Chelates, Irondrug

Amino acid chelated iron capsules contain 15 mg